Doctor Ignacio Jesus Amat Santos

Doctor Ignacio Jesus Amat Santos

Institute of Heart Sciences (ICICOR), Valladolid (Spain)

Dr. Amat-Santos was trained as Cardiologist in University Clinical Hospital of Valladolid (Spain) with an external stay at klinkum Grossadern in Munich (Germany) and has a degree in statistics applied to biosanitary research from the Autonoma University in Barcelona (Spain). He was trained as interventional Cardiologist in the Quebec Heart & Lung institute (Canada) and also as clinical researcher through the Instituto de Salud Carlos III (Madrid, Spain) with a competitive contract “Rio Hortega” obtaining within that period his PhD that received the first national prize. Currently he is the Director of the interventional cardiology department at the University Clinic Hospital of Valladolid, one of the largest in Spain, and is Professor in Medicine in the University of Valladolid where he leads several active Reseach lines.

Presentations

RASTAVI - renin-angiotensin system blocked following TAVI

Event: ESC Congress 2023

Topic: Angiotensin-Renin-Bradykinin System

Session: Late-breaking science on heart failure

Access

Effect of renin-angiotensin system blockade in long term outcomes following transcatheter aortic valve implantation.

Event: ESC Congress 2018

Topic: Angiotensin-Renin-Bradykinin System

Session: Innovative drug therapies

Access

Tricuspid but not mitral regurgitation determines mortality after TAVR in patients with less than significant mitral regurgitation

Event: ESC Congress 2017

Topic: Tricuspid valve disease

Session: Best Posters in aortic valve disease

Access

Acquired intracardiac shunts following transcatheter aortic valve replacement

Event: ESC Congress 2017

Topic: Aortic valve disease

Session: Risk stratification and prognosis after TAVI

Access

Multidetector computed tomography parameters as predictors of improvement of mitral regurgitation after transcatheter aortic valve replacement. A multicentre study.

Event: ESC Congress 2016

Topic: Valvular imaging

Session: Valvular disease

Access

Bailout stenting in coronary bifurcations is associated with increased risk of in-hospital and 1-year adverse outcomes: insights from the P2BiTO registry

Event: ESC Congress 2016

Topic: PCI / stents: devices and technique

Session: PCI and more

Access

Bailout transcatheter aortic valve implantation after aborted sternotomy at the time of surgical aortic valve replacement: a multicenter study

Event: ESC Congress 2016

Topic: Surgery and intervention in valve disease

Session: Valvular disease

Access

Potential candidates to percutaneous therapies on the mitral valve after transcatheter aortic valve implantation: a computed tomography-based multicentre study.

Event: ESC Congress 2016

Topic: Mitral valve interventions

Session: Best Posters in mitral valve interventions

Access

Doctor Ignacio Jesus Amat Santos

Biography

Contributor content

RASTAVI - renin-angiotensin system blocked following TAVI

Effect of renin-angiotensin system blockade in long term outcomes following transcatheter aortic valve implantation.

Tricuspid but not mitral regurgitation determines mortality after TAVR in patients with less than significant mitral regurgitation

Acquired intracardiac shunts following transcatheter aortic valve replacement

Multidetector computed tomography parameters as predictors of improvement of mitral regurgitation after transcatheter aortic valve replacement. A multicentre study.

Bailout stenting in coronary bifurcations is associated with increased risk of in-hospital and 1-year adverse outcomes: insights from the P2BiTO registry

Bailout transcatheter aortic valve implantation after aborted sternotomy at the time of surgical aortic valve replacement: a multicenter study

Potential candidates to percutaneous therapies on the mitral valve after transcatheter aortic valve implantation: a computed tomography-based multicentre study.

ESC 365 is supported by